Aushon Inks Deal with Peking University to ID Protein Biomarkers for Colorectal Cancer

Under the agreement, Aushon will use its protein biomarker detection platform to develop biomarkers to predict liver metastases of colorectal cancer, as well as stratification biomarkers for radio-chemotherapy patients.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.